Perrotta PL - Search Results

1

Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.

Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D, Kacinski BM, Haffty BG. Maher MG, et al. Among authors: perrotta pl. Clin Cancer Res. 1998 Aug;4(8):1851-6. Clin Cancer Res. 1998. PMID: 9717811

2

Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.

Flick MB, Sapi E, Perrotta PL, Maher MG, Halaban R, Carter D, Kacinski BM. Flick MB, et al. Among authors: perrotta pl. Oncogene. 1997 May 29;14(21):2553-61. doi: 10.1038/sj.onc.1201092. Oncogene. 1997. PMID: 9191055

3

Inducible nitric oxide synthase with transitional cell carcinoma of the bladder.

Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM. Swana HS, et al. Among authors: perrotta pl. J Urol. 1999 Feb;161(2):630-4. J Urol. 1999. PMID: 9915473 Free article.

4

Liesegang rings and endometriosis.

Perrotta PL, Ginsburg FW, Siderides CI, Parkash V. Perrotta PL, et al. Int J Gynecol Pathol. 1998 Oct;17(4):358-62. doi: 10.1097/00004347-199810000-00010. Int J Gynecol Pathol. 1998. PMID: 9785137

5

The efficacy of the placental biopsy.

Kliman HJ, Perrotta PL, Jones DC. Kliman HJ, et al. Among authors: perrotta pl. Am J Obstet Gynecol. 1995 Oct;173(4):1084-8. doi: 10.1016/0002-9378(95)91331-9. Am J Obstet Gynecol. 1995. PMID: 7485298

6

Endothelial cell-glucocorticoid receptor interactions and regulation of Wnt signaling.

Zhou H, Mehta S, Srivastava SP, Grabinska K, Zhang X, Wong C, Hedayat A, Perrotta P, Fernández-Hernando C, Sessa WC, Goodwin JE. Zhou H, et al. JCI Insight. 2020 Feb 13;5(3):e131384. doi: 10.1172/jci.insight.131384. JCI Insight. 2020. PMID: 32051336 Free PMC article.

7

Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling.

Landskroner-Eiger S, Qiu C, Perrotta P, Siragusa M, Lee MY, Ulrich V, Luciano AK, Zhuang ZW, Corti F, Simons M, Montgomery RL, Wu D, Yu J, Sessa WC. Landskroner-Eiger S, et al. Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12812-7. doi: 10.1073/pnas.1507094112. Epub 2015 Sep 28. Proc Natl Acad Sci U S A. 2015. PMID: 26417068 Free PMC article.

8

Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice.

Ulrich V, Rotllan N, Araldi E, Luciano A, Skroblin P, Abonnenc M, Perrotta P, Yin X, Bauer A, Leslie KL, Zhang P, Aryal B, Montgomery RL, Thum T, Martin K, Suarez Y, Mayr M, Fernandez-Hernando C, Sessa WC. Ulrich V, et al. EMBO Mol Med. 2016 Jun 1;8(6):643-53. doi: 10.15252/emmm.201506031. Print 2016 Jun. EMBO Mol Med. 2016. PMID: 27137489 Free PMC article.

9

Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.

Perrotta P, Emini Veseli B, Van der Veken B, Roth L, Martinet W, De Meyer GRY. Perrotta P, et al. Vascul Pharmacol. 2019 Jan;112:72-78. doi: 10.1016/j.vph.2018.06.014. Epub 2018 Jun 19. Vascul Pharmacol. 2019. PMID: 29933080 Free article. Review.

10

Animal models of atherosclerosis.

Emini Veseli B, Perrotta P, De Meyer GRA, Roth L, Van der Donckt C, Martinet W, De Meyer GRY. Emini Veseli B, et al. Eur J Pharmacol. 2017 Dec 5;816:3-13. doi: 10.1016/j.ejphar.2017.05.010. Epub 2017 May 5. Eur J Pharmacol. 2017. PMID: 28483459 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page